Effects of the serotonergic anxiolytic buspirone on plasma glucose and glucose-induced hyperglycemia in mice

Journal of Pharmacological Sciences

Volumn 93, Issue 4, 2003, Pages 446-450

  Sugimoto, Yumi ^a   Takashima, Nozomu ^a   Noma, Toshiko ^a   Yamada, Jun ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

5 HT1A receptor; Anxiolytic; Buspirone; Glucose; Insulin

Indexed keywords

1 (2 PYRIMIDINYL)PIPERAZINE; ANXIOLYTIC AGENT; BUSPIRONE; DRUG METABOLITE; GLUCOSE; INSULIN; SEROTONIN RECEPTOR AFFECTING AGENT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG EFFECT; DRUG METABOLISM; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN;

ANIMALS; ANTI-ANXIETY AGENTS; BLOOD GLUCOSE; BUSPIRONE; FASTING; GLUCOSE; HYPERGLYCEMIA; HYPERINSULINISM; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MICE; SEROTONIN AGONISTS; TIME FACTORS;

EID: 1042304298     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.93.446     Document Type: Article

References (23)

1. Deakin JF. The role of serotonin in panic, anxiety and depression. Int Clin Psychopharmacol. 1998;13 Suppl 4:S1-S5.
2. Briley M, Moret C. Neurobiological mechanisms involved in antidepressnat therapies. J Clin Neuropharmacol. 1993;16:24-35.
3. 1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat. J Pharmacol Exp Ther. 1987;243:1159-1166.
4. 2 receptor agonists DOI and α-methyl-5-HT on plasma glucose and insulin levels in the rat. Eur J Pharmacol. 1990;187:435-443.
5. 1A receptor agonists buspirone and ipsapirone activate adrenaline release in the conscious rat. Eur J Pharmacol. 1990;177:107-110.
6. 2 receptor agonist, DOI. Eur J Pharmacol. 1992;213:41-46.
7. 1A receptor agonist buspirone on the blood glucose and pancreatic hormones in rats. Jpn J Pharmacol. 1992;60:145-148.
8. 2C/2B receptor agonist 1-(3-chlorophenyl)piperazine on the plasma glucose levels of rats. Eur J Pharmacol. 1996;307:75-80.
9. Yamada J, Sugimoto Y, Inoue K. Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms. Eur J Pharmacol. 1999;382:211-215.
10. Sugimoto Y, Inoue K, Yamada J. Involvement of serotonin in zimelidine-induced hyperglycemia in mice. Biol Pharm Bull. 1999;22:1240-1241.
11. Sugimoto Y, Inoue K, Yamada J. The tricyclic antidepressant clomipramine increases plasma glucose levels of mice. J Pharmacol Sci. 2003;93:74-79.
12. 2 receptor in imipramine-induced hyperglycemia in mice. Horm Metab Res. 2003;35:511-516.
13. Axelord J, Reisine TD. Stress hormones: Their interaction and regulation. Science. 1983;224:452-459.
14. Sugimoto Y, Noma T, Yamada J. Effects of anxiolytics, diazepam and tandospirone, on immobilization stress-induced hyperglycemia in mice. Life Sci. 1998;63:1221-1226.
15. 1A receptor agonist, are not related to its neuroendocrine effects. Eur J Pharmacol. 1995;280:185-193.
16. Groenink L, van der Gugten J, Zethof TJ, van der Heyden JA, Olivier B. Neuroendocrine effects of diazepam and flesinoxan in the stress-induced hyperthermia test in mice. Pharmacol Biochem Behav. 1996;54:249-254.
17. Caccia S, Conti I, Vigano G, Garattini S. 1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone and rat. Pharmacology. 1986;33:46-51.
18. 1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat. Naunyn Schmiedebergs Arch Pharmacol. 1990;341:381-384.
19. Chaouloff F, Laude D, Baudrie V. Ganglionic transmission is a prerequisite for the adrenaline-releasing and hyperglycemic effects of 8-OH-DPAT. Eur J Pharmacol. 1990;185:11-18.
20. 2-adrenoceptor antagonist activity may account for the effects of buspirone in an anticonflict test in the rat. Eur J Pharmacol. 1988;155:129-137.
21. Gammans RE, Mayol RF, Eison MS. Concentration of buspirone and 1-pyrimidinylpiperazine, a metabolite, in rat brain. Fed Proc. 1983;42:377.
22. Angel I, Bidet S, Langer SZ. Pharmacological characterization of the hyperglycemia induced by alpha-2 adrenoceptor agonists. J Pharmacol Ther. 1988;246:1098-1103.
23. Nakadate T, Nakai T, Muraki T, Kato R. Adrenergic regulation of blood glucose levels: Possible involvement of postsynaptic alpha-2 type adrenergic receptors regulating insulin release. J Pharmacol Exp Ther. 1988;215:226-230.